Unique Spatial Immune Profiling in Pancreatic Ductal Adenocarcinoma with Enrichment of Exhausted and Senescent T Cells and Diffused CD47-SIRPα Expression
Authors:
- Alexandros PapalamprosAPAlexandros Papalampros
- Michail VailasMVMichail Vailas
- Konstantinos NtostoglouKNKonstantinos Ntostoglou
- Maria Lopez ChiloechesMCMaria Lopez Chiloeches
- Stratigoula SakellariouSSStratigoula Sakellariou
- Niki V. ChouliariNCNiki V. Chouliari
- Menelaos G. SamarasMSMenelaos G. Samaras
- Paraskevi D. VeltsistaPVParaskevi D. Veltsista
- Sofia D. P. TheodorouSofia D. P. Theodorou
- Aggelos T. MargetisAMAggelos T. Margetis
- Anna BergonziniABAnna Bergonzini
- Lysandros KarydakisLKLysandros Karydakis
Open Access
Abstract
Background: Pancreatic ductal adenocarcinoma (PDAC) is resistant to single-agent immunotherapies. To understand the mechanisms leading to the poor response to this treatment, a better understanding of the PDAC immune landscape is required. The present work aims to study the immune profile in PDAC in relationship to spatial heterogeneity of the tissue microenvironment (TME) in intact tissues. Methods: Serial section and multiplex in situ analysis were performed in 42 PDAC samples to assess gene and protein expression at single-cell resolution in the: (a) tumor center (TC), (b) invasive front (IF), (c) normal parenchyma adjacent to the tumor, and (d) tumor positive and negative draining lymph nodes (LNs). Results: We observed: (a) enrichment of T cell subpopulations with exhausted and senescent phenotype in the TC, IF and tumor positive LNs; (b) a dominant type 2 immune response in the TME, which is more pronounced in the TC; (c) an emerging role of CD47-SIRPα axis; and (d) a similar immune cell topography independently of the neoadjuvant chemotherapy. Conclusion: This study reveals the existence of dysfunctional T lymphocytes with specific spatial distribution, thus opening a new dimension both conceptually and mechanistically in tumor-stroma interaction in PDAC with potential impact on the efficacy of immune-regulatory therapeutic modalities.Keywords
This publication has 47 references indexed in Scilit:
- Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsiesmAbs, 2015
- T-cell exhaustion in the tumor microenvironmentCell Death & Disease, 2015
- Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual MechanismsClinical Cancer Research, 2015
- Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancerBritish Journal of Cancer, 2015
- Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant TreatmentPLOS ONE, 2014
- T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elementsNature Communications, 2012
- Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancerJournal of Experimental Medicine, 2011
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigmNature Immunology, 2010
- Decreased perforin and granzyme B expression in senescent HIV-1-specific cytotoxic T lymphocytesVirology, 2005
- Interleukin-13 Gene Expression Is Regulated by GATA-3 in T CellsJournal of Biological Chemistry, 2002